QUIDELORTHO CORP
| Market Cap | $1.17B |
| P/E Ratio | — |
| Forward P/E | 5.78 |
| Dividend Yield | — |
| Beta | 0.92 |
| 52W Range | $14.78 - $37.42 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital | 0.02% | $1.71M | 59,783 | Reduce 12.48% |
Insider Trading
| Insider Name of the company insider who made the trade 14 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Blaser Brian J.President and CEO | Buy | 10,540 | $23.59 | $248.66K | 13 Feb 2026 | 13 Feb 2026 |
| Strobeck Matthew | Buy | 10,000 | $23.96 | $239.59K | 13 Feb 2026 | 13 Feb 2026 |
| Busky Joseph M.Chief Financial Officer | Buy | 3,370 | $23.66 | $79.74K | 13 Feb 2026 | 13 Feb 2026 |
| RHOADS ANN D | Buy | 750 | $28.28 | $21.21K | 10 Dec 2025 | 10 Dec 2025 |
| Wilkins Joseph D Jr. | Buy | 370 | $27.96 | $10.34K | 26 Nov 2025 | 01 Dec 2025 |
| Joseph D Wilkins Jr.Director | Buy | 370 | $27.96 | $10.34K | 26 Nov 2025 | 01 Dec 2025 |
| WIDDER KENNETH J | Sale | 4,026 | $27.81 | $111.97K | 25 Nov 2025 | 25 Nov 2025 |
| Kenneth J WidderDirector | Sale | 4,026 | $27.81 | $111.97K | 25 Nov 2025 | 25 Nov 2025 |
| Busky Joseph M.Chief Financial Officer | Buy | 4,770 | $26.06 | $124.31K | 24 Nov 2025 | 25 Nov 2025 |
| Joseph M. BuskyChief Financial Officer | Buy | 4,770 | $26.06 | $124.31K | 24 Nov 2025 | 25 Nov 2025 |
| POLAN MARY LAKE PH D | Buy | 1,000 | $22.43 | $22.43K | 21 Nov 2025 | 24 Nov 2025 |
| Mary Lake PH D PolanDirector | Buy | 1,000 | $22.43 | $22.43K | 21 Nov 2025 | 24 Nov 2025 |
| Blaser Brian J.President and CEO | Buy | 23,500 | $21.34 | $501.58K | 19 Nov 2025 | 20 Nov 2025 |
| Brian J. BlaserPresident and CEO | Buy | 23,500 | $21.34 | $501.58K | 19 Nov 2025 | 20 Nov 2025 |
Frequently Asked Questions
What is QDEL stock price today?
QUIDELORTHO CORP (QDEL) is currently trading at $17.25. The stock has a 52-week range of $14.78 to $37.42 and a market capitalization of $1.17B.
Is QDEL a good stock to buy in 2026?
QUIDELORTHO CORP has a P/E ratio of N/A (forward P/E: 5.8), a dividend yield of none, and 1-year performance of -46.9%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling QDEL stock?
There have been 14 insider transactions for QDEL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has QDEL stock performed over the past year?
QUIDELORTHO CORP (QDEL) has returned -46.9% over the past 12 months. The stock traded between $14.78 and $37.42 during this period, and is currently at $17.25.
Which hedge funds own QDEL (QUIDELORTHO CORP)?
1 tracked hedge funds currently hold QDEL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is QDEL's market cap and valuation?
QUIDELORTHO CORP (QDEL) has a market capitalization of $1.17B. The trailing P/E ratio is N/A and forward P/E is 5.8. The stock is classified in the Healthcare sector.
What is QDEL's revenue and profitability?
QUIDELORTHO CORP reported revenue of $2.73B with net income of N/A and a profit margin of N/A. The stock has a beta of 0.92.
What sector is QDEL in and who are its biggest institutional holders?
QUIDELORTHO CORP (QDEL) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.